UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy

European journal of cancer (1990), 2021-11, Vol.157, p.428-440

2021

Volltextzugriff (PDF)

Adding metabolic agents to prostate cancer therapy: Every rose has its thorn

European journal of cancer (1990), 2022-07, Vol.170, p.305-307

2022

Volltextzugriff (PDF)

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

European journal of cancer (1990), 2022-02, Vol.162, p.148-157

2022

Volltextzugriff (PDF)

Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

European journal of cancer (1990), 2019-11, Vol.121, p.48-54

2019

Volltextzugriff (PDF)

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

European journal of cancer (1990), 2010-11, Vol.46 (16), p.3016-3021

2010

Volltextzugriff (PDF)

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases

European journal of cancer (1990), 2014-03, Vol.50 (5), p.972-980

2014

Volltextzugriff (PDF)

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib

European journal of cancer (1990), 2017-11, Vol.86, p.226-232

2017

Volltextzugriff (PDF)

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study

European journal of cancer (1990), 2011-04, Vol.47 (6), p.831-838

2011

Volltextzugriff (PDF)

The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin

European journal of cancer (1990), 2013-01, Vol.49 (2), p.345-351

2013

Volltextzugriff (PDF)

Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

European journal of cancer (1990), 2019-03, Vol.109, p.12-20

2019

Volltextzugriff (PDF)

Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patients

European journal of cancer (1990), 2023-06, Vol.186, p.113-121

2023

Volltextzugriff (PDF)

Lifestyle habits as a contributor to anti-cancer treatment failure

European journal of cancer (1990), 2008-02, Vol.44 (3), p.374-382

2008

Volltextzugriff (PDF)

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations

European journal of cancer (1990), 2024-05, Vol.202, p.114024, Article 114024

2024

Volltextzugriff (PDF)

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

European journal of cancer (1990), 2023-11, Vol.194, p.113346-113346, Article 113346

2023

Volltextzugriff (PDF)

Medicinal cannabis in oncology

European journal of cancer (1990), 2007-12, Vol.43 (18), p.2638-2644

2007

Volltextzugriff (PDF)

Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study

European journal of cancer (1990), 2022-10, Vol.174, p.113-120

2022

Volltextzugriff (PDF)

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment

European journal of cancer (1990), 2016-03, Vol.56, p.101-106

2016

Volltextzugriff (PDF)

Genotyping and phenotyping cytochrome P450: Perspectives for cancer treatment

European journal of cancer (1990), 2006, Vol.42 (2), p.141-148

2006

Volltextzugriff (PDF)

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

European journal of cancer (1990), 2022-09, Vol.172, p.231-233

2022

Volltextzugriff (PDF)

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?

European journal of cancer (1990), 2022-09, Vol.172, p.231-233

2022

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Oncology
(20)
Science & Technology
(20)
Humans
(17)
Tumors
(12)
Biological And Medical Sciences
(7)
Female
(7)
Hematology, Oncology And Palliative Medicine
(7)
Male
(7)
Medical Sciences
(7)
Pharmacology. Drug Treatments
(7)
Neoplasms - Drug Therapy
(6)
Patients
(6)
Pharmacokinetics
(5)
Retrospective Studies
(5)
Toxicity
(5)
Cancer
(4)
Middle Aged
(4)
Prospective Studies
(4)
Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(22)
IngentaConnect
(22)
Access via ScienceDirect (Elsevier)
(22)
MEDLINE
(17)
IngentaConnect Journals
(7)

Menü

Weitere Dienste

Einstellungen

Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy

Adding metabolic agents to prostate cancer therapy: Every rose has its thorn

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study

The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin

Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patients

Lifestyle habits as a contributor to anti-cancer treatment failure

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

Medicinal cannabis in oncology

CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients

Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment

Genotyping and phenotyping cytochrome P450: Perspectives for cancer treatment

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?

Aktive Filter

Suchergebnisse filtern